Catalyst Wire Dossier Catalyst Wire Dossier

Endostatin Adenovirus

endostatin adenovirus vector
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Endostatin Adenovirus, covering 2025-09-04 to 2025-09-04. Get the full timeline:

Most recent: Clinical Trial Update: Endostatin Adenovirus With Checkpoint Inhibitor in Advanced Head and Neck or Esophageal Cancer [Phase 1]

See pricing